Tolerability of internal low-energy shock strengths currently needed for endocardial atrial cardioversion

American Journal of Cardiology

Volumn 80, Issue 11, 1997, Pages 1489-1490

  Jung, Jens ^a   Heisel, Armin ^a   Fries, Roland ^a   Köllner, Volker ^b  

^a SAARLAND UNIVERSITY   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVERSION; CLINICAL ARTICLE; ELECTRIC SHOCK; ENERGY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL;

ATRIAL FIBRILLATION; ELECTRIC COUNTERSHOCK; ELECTRIC IMPEDANCE; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0030785475     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00733-9     Document Type: Article

References (6)

1. Lau CP, Tse HF, Lok NS, Lee KL, Ho DS, Sopher M, Murgatroyd F, Camm AJ. Initial clinical experience with an implantable human atrial defibrillator. PACE. 20:(pt. II):1997;220-225.
2. Murgatroyd FD, Slade AK, Sopher SM, Rowland E, Ward DE, Camm AJ. Efficacy and tolerability of transvenous low energy cardioversion in paroxysmal atrial fibrillation in humans. J Am Coll Cardiol. 25:1995;1347-1353.
3. Saksena S, Prakash A, Mangeon L, Varanasi S, Kolettis T, Methew P, De Groot P, Mehra R, Krol R. Clinical efficacy and safety of atrial defibrillation using biphasic shocks and current nonthoracotomy endocardial lead configurations. Am J Cardiol. 76:1995;913-921.
4. Hillsey RE, Wharton JM. Implantable atrial defibrillators. J Cardiovasc Electrophysiol. 6:1995;634-648.
5. Tomassoni G, Newby KH, Kearney MM, Brandon MJ, Barold H, Natale A. Testing different biphasic waveforms and capacitances effect on atrial defibrillation threshold and pain perception . J Am Coll Cardiol. 28:1996;695-699.
6. Sra JS, Maglio C, Dhala A, Blanck Z, Biehl M, Deshpande S, Keelan ET, Jazayeri MR, Akhtar M. Feasibility of atrial fibrillation detection and use of a preceding synchronization interval as a criterion for shock delivery in humans with atrial fibrillation. J Am Coll Cardiol. 228:1996;1532-1538.